Dr. Dorothy Hatsukami Presents This Year's Eric D. Hadar Distinguished Lecture

November 13, 2020

(New York, NY) - This year’s Eric D. Hadar Distinguished Lecture at the Columbia University Department of Psychiatry will take place on November 18th, 2020. This year’s lecturer will be Dr. Dorothy Hatsukami, who will present her talk, “Tobacco Harm Reduction: Controversies and a Path Forward,” at 11:00 am in a virtual lecture. 

This event is a part of the annual lecture series on substance use disorders sponsored by the Eric D. Hadar Family Foundation. The Foundation’s generous commitment of $2 million was given to support the work of the Division on Substance Use Disorders. A portion of this gift included an endowed fund of $750,000 for the annual Hadar Distinguished Lecture. The remaining amount established the Eric D. Hadar Research Fund, advancing research by providing resources for fellowship and faculty support, research projects, and laboratory infrastructure. 

Eric Hadar is Chairman and CEO of Allied Partners, the real estate investment, development, and asset management company he founded in 1993. He also is a member of the Samaritan Daytop Foundation Board of Trustees, which raises money to support Samaritan Daytop Village, a human services agency that provides addiction recovery and support. 

Since 2016, the Eric D. Hadar Distinguished Lecture series has expanded understanding of both substance use and the treatments available to those dealing with these disorders. Previous speakers include Markus Heilig, MD PhD, Director of the Center for Social and Affective Neuroscience at Linköping University, who spoke about the need to update how studies on alcohol addiction are conducted; Dr. Kathleen M. Carroll, Principal Investigator of the Center for Psychotherapy Development at Yale, who spoke on moving validated behavioral therapies from the research clinic to the real world via the Stage Model; Dr. Paula Riggs, the Director of the Division of Substance Dependence at the University of Colorado Denver, who spoke on the public health impact and clinical implications of marijuana legalization; and Professor Sir John Strang, the head of the National Addictions Centre at Kings College London, who spoke on preventing opiate overdose deaths. 

Dorothy K. Hatsukami, Ph.D. is the Professor of Psychiatry and Behavioral Sciences, Forster Family Chair in Cancer Prevention and Associate Director of Cancer Prevention and Control of the Masonic Cancer Center at the University of Minnesota. Her areas of expertise include nicotine addiction and its treatment and tobacco regulatory science assessing the toxicity, appeal and addictiveness of various tobacco products. She has over 450 peer reviewed publications and has received a number of awards for her work. She has served on numerous scientific advisory boards or councils for the U.S. government including NIDA, SAMSHA, ONDCP, Interagency Committee on Smoking and Health, and the FDA Tobacco Product Scientific Advisory Committees. She is currently a member of the World Health Organization Study Group on Tobacco Product Regulation. She served as president of two scientific organizations, the College on Problems of Drug Dependence and the Society for Research on Nicotine and Tobacco. 


Columbia University Department of Psychiatry 

Columbia Psychiatry is among the top ranked psychiatry departments in the nation and has contributed greatly to the understanding and treatment of brain disorders. Co-located at the New York State Psychiatric Institute on the NewYork-Presbyterian Hospital/Columbia University Irving Medical Center campus in Washington Heights, the department enjoys a rich and productive collaborative relationship with physicians in various disciplines at the Columbia University Vagelos College of Physicians and Surgeons. Columbia Psychiatry is home to distinguished clinicians and researchers noted for their clinical and research advances in the diagnosis and treatment of depression, suicide, schizophrenia, bipolar and anxiety disorders, eating disorders, substance use disorders, and childhood psychiatric disorders.